CLSI M24-A2-2011
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard- Second Edition
- Standard No.
- CLSI M24-A2-2011
- Release Date
- 2011
- Published By
- US-CLSI
- Latest
- CLSI M24-A2-2011
- Scope
- CLSI document M24-A2 contains protocols for the susceptibility testing of three major categories of mycobacterial species (Mycobacterium tuberculosis complex [MTBC]; the slowly growing nontuberculous mycobacteria [NTM]; and the rapidly growing mycobacteria) and recommendations for susceptibility testing of Nocardia spp. and miscellaneous aerobic actinomycetes. This document also provides guidance on the selection of primary and, for some organisms, secondary agents for testing and reporting; instructions for performing the standard agar proportion method for MTBC and broth microdilution for NTM; and quality control (QC) protocols for each organism category. Testing and reporting recommendations and principles of QC procedures apply to use of commercial shorter-incubation broth systems that have been cleared by the US Food and Drug Administration (FDA) for testing MTBC, as well as the reference methods.
CLSI M24-A2-2011 history
- 2011 CLSI M24-A2-2011 Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard- Second Edition
